Twice-Weekly Brincidofovir (CMX001) Shows Promising Antiviral Activity in Immunocompromised Transplant Recipients With Asymptomatic Adenovirus Viremia

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.12.120

Related search